FBRX · Forte Biosciences, Inc.
$76.53
-0.12 (-0.16%)
At close · Jul 29
Market Cap
$1.06B
Shares
13.89M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-27 | 2026-07-26 | |
| 8-K | 2026-07-09 | — | |
| 8-K | 2026-06-02 | 2026-05-29 | |
| 8-K | 2026-05-14 | 2026-05-11 | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-05-29 | |
| 8-K | 2026-04-09 | 2026-04-08 | |
| 8-K | 2026-04-01 | 2026-03-31 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-25 | 2025-06-24 | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-05-30 | 2025-05-29 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| DEF 14A | 2025-04-30 | 2025-05-29 | |
| 8-K | 2025-04-18 | — | |
| 8-K | 2025-04-04 | 2025-03-31 | |
| 10-K | 2025-03-28 | 2024-12-31 | |
| 8-K | 2025-01-24 | — | |
| DEF 14A | 2024-12-31 | 2025-01-24 | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-20 | 2024-11-19 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-09-20 | 2024-09-17 | |
| 8-K | 2024-08-30 | 2024-08-27 | |
| 8-K | 2024-08-22 | 2024-08-20 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| DEF 14A | 2024-07-30 | 2024-08-20 | |
| 8-K | 2024-06-14 | 2024-06-11 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 10-K | 2024-03-18 | 2023-12-31 | |
| 8-K | 2024-03-18 | — | |
| 8-K/A | 2024-02-16 | 2023-09-19 | |
| 8-K | 2023-12-08 | 2023-12-04 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K/A | 2023-09-26 | 2023-09-19 | |
| 8-K | 2023-09-20 | 2023-09-14 | |
| 8-K | 2023-09-20 | 2023-09-19 | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-08-04 | 2023-07-31 | |
| 8-K | 2023-08-01 | 2023-07-28 | |
| 8-K | 2023-06-26 | — |
Showing 1–50 of 104 filings